Metastatic Bladder Cancer

2

Review clinical trials related to Metastatic Bladder Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

The goal of this study is to evaluate the feasibility and preliminary efficacy of a combined acupuncture and exercise intervention for the management of chemotherapy-induced peripheral neuropathy (CIPN) in participants with metastatic bladder cancer receiving enfortumab vedotin (EV) and pembrolizumab (Pembro). The names of the two study groups in this research study are: * Acupuncture + Virtual Exercise (AVE) * Virtual Exercise Only (VE)

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: May 4, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years old [+10]

History of peripheral neuropathy prior to EV-Pembro initiation [+6]

Status: Recruiting

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

The goal of this study is to better understand how to best treat participants with advanced bladder cancer who may not be able to tolerate all of the chemotherapy drugs that have been shown to be effective. In this study, investigators are assessing the role of the survey, the Geriatric-8, and its ability to predict outcomes in older participants undergoing cancer treatments. Additionally, investigators are evaluating the differential impact of treatments on quality of life in an older and at risk population.

Participants needed: 180
Trial details
Age: 65+Biological sex: AllType: ObservationalSponsor: Dana-Farber Cancer InstituteUpdated: Feb 17, 2026Locations: 1
Eligibility criteria

Age ≥65-years-old (study will limit total enrollment of patients between ages 65... [+4]

Subjects who elect to not undergo cancer-directed therapy [+3]